跳至主要内容
临床试验/ISRCTN23620802
ISRCTN23620802已完成不适用

An interventional study to investigate the effect of riboflavin supplementation (1.6mg/d/16weeks) on blood pressure in hypertensive individuals who are homozygous for the 677Câ T polymorphism (TT genotype) in the gene encoding the enzyme methylenetetrahydrofolate reductase (MTHFR)

niversity of Ulster (UK)0 个研究点目标入组 80 人开始时间: 2012年2月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Individuals recruited previously who consented to being contacted regarding future studies
  • 2. Individuals identified as having the TT genotype

排除标准

  • 1. A history of gastrointestinal, hepatic, renal or haematological disorders
  • 2. Are taking B vitamin supplements, anticonvulsant therapy or any other drugs known to interfere with folate / B vitamin metabolism

研究者

发起方
niversity of Ulster (UK)

相似试验